(NASDAQ:JBIO), SAN FRANCISCO and VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in the following upcoming conferences: Cantor Global Healthcare Conference (September 3-5, 2025)Fireside Chat: Tuesday, September 3 at 3:20 p.m. ET Stifel […]
(NasdaqGM:IMAB), Dr. Robert Lenz, Ms. Xin Liu and Dr. Sean Cao appointed to the Board of Directors Research and Development Committee established to accelerate innovation and long-term growth Dr. Ken Takeshita appointed to the Scientific Advisory Board ROCKVILLE, Md., Aug. 25, 2025 (GLOBE NEWSWIRE) — I-Mab (NASDAQ:IMAB) (the Company), a U.S.-based, global biotech company, focused
(NasdaqGM:CSTL), New validation study shows DecisionDx-SCC significantly outperforms current staging systems in predicting risk of local recurrence and metastasis for NCCN high-risk patients Clinician survey confirms test results align with treatment decision-making thresholds for adjuvant radiation therapy and surveillance imaging FRIENDSWOOD, Texas, Aug. 25, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company
(NASDAQ:IBIO), Total gross proceeds of $100 million if all Series G warrants and Series H warrants are exercised for cash Financing was led by Balyasny Asset Management and included participation from Cormorant Asset Management, Adage Capital Partners LP, Ally Bridge Group, Marshall Wace, Coastlands Capital, SilverArc Capital Management, Vestal Point Capital, and Ausangate Capital SAN
(NASDAQ:BEAM), CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in fireside chats at the following upcoming investor conferences: Citi's 2025 Biopharma Back to School Conference on Wednesday, September 3, 2025, at 4:00 p.m. ET
(NasdaqGM:CLYM), WELLESLEY HILLS, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of its executive team will participate in the upcoming investor conferences detailed below. Cantor Global Healthcare ConferenceLocation: New York, NYFormat: Fireside chat and one-on-one investor meetingsDate: Friday,
(TSX:MDI), MONCTON, New Brunswick, Aug. 25, 2025 (GLOBE NEWSWIRE) — Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release its first quarter results, ended July 31, 2025, on Monday, September 8, 2025 after the markets have closed. Webcast/Conference Call Details Denis Larocque, President & Chief Executive Officer, and Ian Ross, Chief Financial Officer,
GRAND RAPIDS, Mich., Aug. 25, 2025 (GLOBE NEWSWIRE) — Edustaff, a national leader in K-12 substitute and support staffing solutions, proudly announces its inaugural partnership in Alabama with Anniston City Schools, marking the company's first district collaboration in the state. Serving approximately 1,909 students across five schools–including three elementary campuses, a middle school, and a
JPMorgan Announces Cash Distributions for the JPMorgan ETFs GlobeNewswire August 25, 2025 TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) — J. P. Morgan Asset Management (JPMAM)* today announced the final August 2025 cash distributions for the below listed JPMorgan ETFs. The JPMorgan ETFs trade on the Toronto Stock Exchange (TSX). Unitholders of record on September 2,
(NasdaqGM:EDAP), AUSTIN, Texas, August 25, 2025 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to participate in a fireside chat and host 1×1 investor meetings at the H.C. Wainwright 27th Annual Global Investment Conference, which is being held